Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference
03 Janvier 2025 - 12:59PM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will present at J.P. Morgan’s 43rd Annual Healthcare
Conference on Monday, January 13, 2025.
The company’s presentation and participation in a fireside chat
will begin at 7:30 a.m. PT/10:30 a.m. ET.
The event will be webcast simultaneously at
http://investor.bms.com, with materials related to the presentation
available at the start of the live webcast. A replay and archived
edition of the presentation will be available following the
conclusion of the event.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250103085178/en/
Media: media@bms.com Investors:
investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Bristol Myers Squibb (NYSE:BMY)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025
